Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Other Working Capital Changes of $529000.0 for Q3 2025, down 75.52% year-over-year from $2.2 million in Q3 2024, and down 33.21% quarter-over-quarter from $792000.0 in Q2 2025.
Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Other Working Capital Changes history runs 15 years deep, the most recent figure standing at $529000.0 for Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 75.52% year-over-year to $529000.0; the TTM figure through Sep 2025 stood at -$9.6 million (up 63.72% YoY), while the FY2024 annual figure was -$14.5 million, down 135.47% from the prior year.
- Other Working Capital Changes for Q3 2025 stood at $529000.0, down from $792000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $89.8 million in Q4 2023, with the low at -$54.9 million in Q1 2024.
- The 5-year median for Other Working Capital Changes is $516000.0 (2022), against an average of $1.9 million.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes plunged 1715.68% in 2021, then jumped 905.34% in 2022.
- Jazz Pharmaceuticals' Other Working Capital Changes stood at -$21.4 million in 2021, then soared by 54.14% to -$9.8 million in 2022, then tumbled by 171.43% to -$26.7 million in 2023, then surged by 44.32% to -$14.9 million in 2024, then soared by 103.56% to $529000.0 in 2025.
- Business Quant data shows JAZZ's Other Working Capital Changes at $529000.0 in Q3 2025, $792000.0 in Q2 2025, and $4.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.90 Mn |
| Jun 30, 2026 | -4.90 Mn |
| Jun 30, 2026 | -4.90 Mn |
| Mar 31, 2026 | -51.90 Mn |
| Mar 31, 2026 | -51.90 Mn |
| Mar 31, 2026 | -51.90 Mn |
| Dec 31, 2025 | -27.49 Mn |
| Dec 31, 2025 | -27.49 Mn |
| Dec 31, 2025 | -27.49 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 33.19 Mn |
| Jun 30, 2025 | 33.19 Mn |
| Jun 30, 2025 | 33.19 Mn |
| Mar 31, 2025 | -41.40 Mn |
| Mar 31, 2025 | -41.40 Mn |
| Mar 31, 2025 | -41.40 Mn |
| Dec 31, 2024 | 22.84 Mn |
| Dec 31, 2024 | 22.84 Mn |